Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Klebsiella pneumoniae ST147 co-harbouring NDM and OXA-48 outbreak in Rome, Italy

PROVIDER: PRJNA1260529 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR33475238_1.fastq.gz	Fastqsanger.gz
	SRR33475238_2.fastq.gz	Fastqsanger.gz
	SRR33475239_1.fastq.gz	Fastqsanger.gz
	SRR33475239_2.fastq.gz	Fastqsanger.gz
	SRR33475240_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

null

Project description:Klebsiella pneumoniae ST147 OXA-48 and NDM-1 outbreak isolates from healthcare network in Latvia

| PRJEB89896 | ENA

Klebsiella pneumoniae cultivar:Andraeas E. Zautner

Project description:OXA-48/NDM positive Klebsiella pneumoniae outbreak on a COVID-19 ward

| PRJNA1134648 | ENA

Clinical Evaluation of Advanced MALDI-TOF MS for Carbapenemase Subtyping in Gram-negative Isolates

Project description:The spread of carbapenemase-producing Enterobacterales (CPE) is emerging as a significant clinical concern in tertiary hospitals and in particular, long-term care facilities with deficiencies in infection control. This study aims to evaluate an advanced matrix-assisted laser desorption/ionization mass spectrometry (A-MALDI) method for the identification of carbapenemases and further discrimination of their subtypes in clinical isolates. The A-MALDI method was employed to detect CPE target proteins. Enhancements were made to improve detectability and mass accuracy through the optimization of MALDI-TOF settings and internal mass calibration. A total of 581 clinical isolates were analyzed, including 469 CPE isolates (388 KPC, 51 NDM, 40 OXA, and 2 GES) and 112 carbapenemase-negative isolates. Clinical evaluation of the A-MALDI demonstrated 100% accuracy and precision in identifying all the collected CPE isolates. Additionally, A-MALDI successfully discriminated individual carbapenemase subtypes (KPC-2 or KPC-3/4; OXA-48 or OXA-181 or OXA-232; GES-5 or GES-24) and also differentiated co-producing carbapenemase strains (KPC & NDM; KPC & OXA; KPC & GES; NDM & OXA), attributed to its high mass accuracy and simultaneous detection capability. A-MALDI is considered a valuable diagnostic tool for accurately identifying CPE and carbapenemase’s subtypes in clinical isolates. It may also aid in selecting appropriate antibiotics for each carbapenemase subtype. Ultimately, we expect that the A-MALDI method will contribute to preventing the spread of antibiotic resistance and improving human public health.

2024-11-26 | PXD058284 | Pride

Project description:NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy

| PRJNA667843 | ENA

Project description:Molecular in-depth evaluations of OXA-48 and NDM-1 Co-harboring Klebsiella pneumoniae isolates

| PRJNA1193841 | ENA

Klebsiella pneumoniae

Project description:Emergence of Klebsiella pneumoniae clinical isolates co-producing NDM-5 and OXA-48-like in Nepal

| PRJDB8799 | ENA

Project description:Escherichia coli and Klebsiella pneumoniae harbouring OXA-48-type carbapenemases Genome sequencing

| PRJNA390933 | ENA

Project description:OXA-48-producing Enterobacteriaceae Hospital Outbreak

| PRJNA517677 | ENA

Klebsiella pneumoniae subsp. pneumoniae

Project description:Investigation of a suspected outbreak of ST147 Klebsiella pneumoniae in Sienna Italy

| PRJNA725484 | ENA

ECDC Klebsiella pneumoniae NDM-1 OXA-48

Project description:European study on Klebsiella pneumoniae carrying both NDM-1 and OXA-48

| PRJEB35890 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data